Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04832854 |
|---|---|
| Brief Title: | A Study Evaluating the Safety and Efficacy of Neoadjuvant and Adjuvant Tiragolumab Plus Atezolizumab, With or Without Platinum-Based Chemotherapy, in Participants With Previously Untreated Locally Advanced Resectable Stage II, IIIA, or Select IIIB Non-Small Cell Lung Cancer |
| First Submitted : | April 2, 2021 |
| First Submitted that Met QC Criteria : | April 2, 2021 |
| First Posted : | April 6, 2021 |
| Last Update Submitted that Met QC Criteria : | May 24, 2023 |
| Last Update Posted : | May 25, 2023 |